| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $83K | — | -46.1% |
| SG&A Expense | $101K | — | +17.0% |
| Operating Income | -$625K | — | +4.7% |
| Pre-tax Income | -$894K | — | -22.3% |
| Net Income | -$894K | — | -22.3% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $37K | -35.8% | +46.7% |
| Total Assets | $206K | -25.5% | -21.7% |
| Current Liabilities | $3.4M | -7.3% | +9.2% |
| Total Liabilities | $3.4M | -8.0% | +8.4% |
| Stockholders' Equity | -$3.2M | +6.6% | -11.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$663K | — | -11.7% |
| Financing Cash Flow | $643K | — | +8.3% |